Inari Medical, Inc. reaffirmed revenue guidance for the full year 2022. For the year, company reaffirming revenue guidance range of $360 million to $370 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.65 USD | -0.04% | +3.08% | -26.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.49% | 2.77B | |
+75.37% | 12.54B | |
-23.11% | 7.71B | |
+8.40% | 6.72B | |
+12.49% | 5.38B | |
+34.82% | 4.89B | |
-15.69% | 4.71B | |
-25.08% | 3.75B | |
+51.37% | 2.55B | |
+0.25% | 2.05B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2022